In the final episode, ‘Key Takeaways in Colorectal Cancer Screening,’ the faculty emphasize that while colonoscopy remains the gold standard, noninvasive stool-based tests are appropriate alternatives for average-risk patients who decline invasive screening.
In ‘Coordinating Care After Abnormal Colorectal Cancer Screening Results,’ the expert faculty focus on the critical importance of timely follow-up after a positive colorectal cancer screening test.
In this episode, ‘Addressing Access Barriers in Colorectal Cancer Screening,’ the panelists explore common patient concerns about the cost of colonoscopy following a positive colorectal cancer screening test.
This episode, titled ‘Individualizing When to Stop Colorectal Cancer Screening,’ examines the nuanced decision-making involved in determining when to discontinue colorectal cancer screening.
In ‘Overcoming Barriers and Advancing Precision in Colorectal Cancer Screening,’ our experts delve into the ongoing challenges and future directions in colorectal cancer screening implementation.
In this episode, ‘Comparing Colorectal Cancer Screening Test Performance and Prep Options,’ the panelists review the performance characteristics of available colorectal cancer screening modalities, including colonoscopy, FIT, multi-target stool DNA, RNA-based tests, and blood-based assays.
In ’Shared Decision-Making in Colorectal Cancer Screening’, the panelists focus on practical strategies for engaging patients in colorectal cancer screening conversations and improving screening uptake.
In ’Shared Decision-Making in Colorectal Cancer Screening’, the panelists focus on practical strategies for engaging patients in colorectal cancer screening conversations and improving screening uptake.
The expert faculty explore how clinicians approach rectal bleeding and surveillance decisions in colorectal cancer screening.
In this episode title, ‘Shifting Epidemiology and Risk Factors in Colorectal Cancer,’ the moderator introduces the evolving landscape of colorectal cancer screening and highlights the growing importance of early detection.
FMX 2025 highlights for primary care include expert insights on vaccine confidence, chronic cough management, and vascular disease prevention.
Panelists discuss billing and coding procedures for skin scanning devices, focusing on the use of unlisted Current Procedural Terminology (CPT) 99 codes with proper documentation and modifiers, the importance of clear communication with billing teams, available educational resources to aid primary care settings, and operational considerations including scope-of-practice variations for device use among clinical staff.
Panelists discuss an interactive case session emphasizing the nuanced evaluation of suspicious skin lesions, highlighting tools such as the DermaSensor for risk scoring, the ugly duckling concept, and the importance of combining clinical judgment with technology to guide biopsy decisions and patient follow-up across diverse skin types.
Panelists discuss that decisions to forgo biopsy often weigh patient risk and lesion characteristics with noninvasive tools offering valuable reassurance; while familiarity with artificial intelligence (AI) aids varies, these technologies—used judiciously and alongside clinical expertise—can boost diagnostic confidence, though limitations and integration challenges remain.
Panelists discuss that successful adoption of artificial intelligence (AI) skin cancer detection tools requires proven effectiveness, easy integration into clinical workflows, appropriate reimbursement, and use as supportive aids that complement—not replace—clinical judgment.
Panelists discuss how visual examination remains the primary method for evaluating suspicious skin lesions in everyday practice, emphasizing clinical judgment, patient-reported changes, and the growing—but still limited—role of artificial intelligence (AI) tools, while underscoring the importance of vigilance, especially in high-risk and underserved populations with limited access to dermatology.
Panelists discuss the challenges of skin cancer evaluations, highlighting patient fears, systemic access barriers, and provider concerns about overreferral, while emphasizing the importance of clear communication, responsible resource use, and cautious adoption of emerging tools such as artificial intelligence (AI), with clinical judgment and trusted educational resources remaining central to care.
Panelists discuss the anxieties primary care providers face in skin cancer evaluation—particularly the fear of missing a malignancy—while highlighting challenges such as limited diagnostic confidence, delayed dermatology access, and disparities in underserved areas, emphasizing the need for better tools and support to empower frontline clinicians and improve early detection.
Panelists discuss the vital role of primary care providers in early skin cancer detection, highlighting the need for improved diagnostic confidence, integration of artificial intelligence (AI) tools, and efficient workflows to overcome time and resource constraints, ultimately aiming to reduce delays and improve patient outcomes.
Drs John Russell, Jacinda Abdul-Mutakabbir, Charles Vega, Wendy Wright, And Neil Skolnik provide their practice pearls and key thoughts on how to vaccinate their patient populations in the upcoming influenza season.
Drs Jacinda Abdul-Mutakabbir and Charles Vega share their expertise on how to vaccinate a 65-year-old male patient with an egg allergy.
A panel of experts in vaccination efforts discuss the available influenza vaccines for a 50-year-old male patient with a heart disease.
John Russell, MD, FAAFP, presents the case of a 30-year-old pregnant woman in her 2nd trimester and reviews the appropriate vaccination strategies for this patient.
Dr John Russell and Neil Skolnik comment on how to translate the advisory committee on immunization practices influenza vaccination recommendations to patients.
Dr Neil Skolnik reviews the role of real-world data to examine the efficacy of influenza vaccines and their impact on influenza related complications.
A panel of experts in vaccination share their thoughts on the optimal timing and administration of an influenza vaccine for the general public.
Dr Wendy Wright reviews the differences between influenza strains and the rationale for the inclusion of multiple viral strains within flu vaccines.
Neil Skolnik, MD, reviews the currently available vaccine technologies, highlighting their mechanisms of action and individual delivery methods.
A panel of experts in vaccination uptake strategies discuss their best practices for empowering their patients to obtain flu vaccines and discuss how to personalize these conversations.
Jacinda Abdul-Mutakabbir, PHARMD, MPH, AAHIVP, leads a conversation on the importance of vaccination in the defense and protection against viral infections, such as the flu.
